Pfizer is getting nearer to the US authorities deal for extra doses

Walgreens pharmacist Jessica Sahni will hold the vaccine against Pfizer BioNTech coronavirus disease (COVID-19) at the New Jewish Home in New York on December 21, 2020.

Yuki Iwamura | Reuters

The U.S. government is about to sign a deal with Pfizer for up to 100 million additional doses of its coronavirus vaccine, a source told CNBC’s Meg Tirrell on Tuesday.

The deal could be announced on Wednesday, according to the source. The New York Times reported the news first.

Pfizer declined to comment, saying the company “cannot comment on confidential discussions that may be taking place with the US government.” The U.S. Department of Health did not immediately respond to a request for comment.

The news comes after Pfizer CEO Dr. Albert Bourla told CNBC last week that the company is negotiating with the federal government to provide an additional 100 million Covid-19 vaccine doses next year.

Pfizer and the US are working out the timing details, Bourla said in an interview with CNBC’s “Squawk Box” on Dec. 14. The company could provide many of these cans in the third quarter of 2021, but the U.S. government is pushing for them in the second quarter, he said.

“We are working very cooperatively to find a solution and allocate that 100 million [doses] if possible in the second quarter or in many of them, “Bourla said, adding that the company has not yet signed an agreement with the US.

Pfizer has already signed a contract with the US government to supply 100 million doses of the vaccine as part of Operation Warp Speed, enough to vaccinate 50 million people. Under the agreement, the Americans will receive the vaccine for free.

This is a developing story. Please try again.

Comments are closed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More